ID   ANKS6_HUMAN             Reviewed;         871 AA.
AC   Q68DC2; A0SE62; Q5VSL0; Q5VSL2; Q5VSL3; Q5VSL4; Q68DB8; Q6P2R2; Q8N9L6;
AC   Q96D62;
DT   06-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT   06-DEC-2005, sequence version 2.
DT   18-JUN-2025, entry version 178.
DE   RecName: Full=Ankyrin repeat and SAM domain-containing protein 6;
DE   AltName: Full=Ankyrin repeat domain-containing protein 14;
DE   AltName: Full=SamCystin;
DE   AltName: Full=Sterile alpha motif domain-containing protein 6;
DE            Short=SAM domain-containing protein 6;
GN   Name=ANKS6; Synonyms=ANKRD14, PKDR1, SAMD6;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=16207829; DOI=10.1681/asn.2005060601;
RA   Brown J.H., Bihoreau M.-T., Hoffmann S., Kranzlin B., Tychinskaya I.,
RA   Obermuller N., Podlich D., Boehn S.N., Kaisaki P.J., Megel N., Danoy P.,
RA   Copley R.R., Broxholme J., Witzgall R., Lathrop M., Gretz N., Gauguier D.;
RT   "Missense mutation in sterile alpha motif of novel protein SamCystin is
RT   associated with polycystic kidney disease in (cy/+) rat.";
RL   J. Am. Soc. Nephrol. 16:3517-3526(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L.,
RA   Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S.,
RA   Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K.,
RA   Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C.,
RA   Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E.,
RA   Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M.,
RA   Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J.,
RA   Frankish A., Frankland J.A., French L., Fricker D.G., Garner P.,
RA   Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S.,
RA   Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E.,
RA   McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V.,
RA   Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S.,
RA   Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K.,
RA   Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J.,
RA   Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M.,
RA   West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L.,
RA   Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J.,
RA   Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 94-871 (ISOFORM 1), AND VARIANT
RP   ILE-644.
RC   TISSUE=Fetal kidney, and Uterus;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 322-871 (ISOFORM 1), AND VARIANT
RP   ILE-644.
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 533-871 (ISOFORM 3), AND VARIANT
RP   ILE-644.
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-657; SER-734 AND SER-742, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   INTERACTION WITH NEK8.
RX   PubMed=26967905; DOI=10.1371/journal.pgen.1005894;
RA   Grampa V., Delous M., Zaidan M., Odye G., Thomas S., Elkhartoufi N.,
RA   Filhol E., Niel O., Silbermann F., Lebreton C., Collardeau-Frachon S.,
RA   Rouvet I., Alessandri J.L., Devisme L., Dieux-Coeslier A., Cordier M.P.,
RA   Capri Y., Khung-Savatovsky S., Sigaudy S., Salomon R., Antignac C.,
RA   Gubler M.C., Benmerah A., Terzi F., Attie-Bitach T., Jeanpierre C.,
RA   Saunier S.;
RT   "Novel NEK8 Mutations Cause Severe Syndromic Renal Cystic Dysplasia through
RT   YAP Dysregulation.";
RL   PLoS Genet. 12:e1005894-e1005894(2016).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (1.50 ANGSTROMS) OF 771-840 IN COMPLEX WITH ANKS3,
RP   INTERACTION WITH ANKS3, DOMAIN, AND MUTAGENESIS OF GLU-798; ASP-811 AND
RP   ARG-823.
RX   PubMed=24998259; DOI=10.1186/1472-6807-14-17;
RA   Leettola C.N., Knight M.J., Cascio D., Hoffman S., Bowie J.U.;
RT   "Characterization of the SAM domain of the PKD-related protein ANKS6 and
RT   its interaction with ANKS3.";
RL   BMC Struct. Biol. 14:17-17(2014).
RN   [12]
RP   VARIANTS TRP-222; GLN-440; SER-640; ILE-644 AND ALA-735.
RX   PubMed=18434273; DOI=10.1016/j.ejmg.2008.02.007;
RA   Kaisaki P.J., Bergmann C., Brown J.H., Outeda P., Lens X.M., Peters D.J.,
RA   Gretz N., Gauguier D., Bihoreau M.T.;
RT   "Genomic organization and mutation screening of the human ortholog of Pkdr1
RT   associated with polycystic kidney disease in the rat.";
RL   Eur. J. Med. Genet. 51:325-331(2008).
RN   [13]
RP   VARIANTS NPHP16 PRO-312 AND ARG-441, FUNCTION, INTERACTION WITH INVS; NEK8
RP   AND NPHP3, AND DOMAIN.
RX   PubMed=23793029; DOI=10.1038/ng.2681;
RA   Hoff S., Halbritter J., Epting D., Frank V., Nguyen T.M., van Reeuwijk J.,
RA   Boehlke C., Schell C., Yasunaga T., Helmstadter M., Mergen M., Filhol E.,
RA   Boldt K., Horn N., Ueffing M., Otto E.A., Eisenberger T., Elting M.W.,
RA   van Wijk J.A., Bockenhauer D., Sebire N.J., Rittig S., Vyberg M., Ring T.,
RA   Pohl M., Pape L., Neuhaus T.J., Elshakhs N.A., Koon S.J., Harris P.C.,
RA   Grahammer F., Huber T.B., Kuehn E.W., Kramer-Zucker A., Bolz H.J.,
RA   Roepman R., Saunier S., Walz G., Hildebrandt F., Bergmann C.,
RA   Lienkamp S.S.;
RT   "ANKS6 is a central component of a nephronophthisis module linking NEK8 to
RT   INVS and NPHP3.";
RL   Nat. Genet. 45:951-956(2013).
CC   -!- FUNCTION: Required for renal function. {ECO:0000269|PubMed:23793029}.
CC   -!- SUBUNIT: Homooligomer (By similarity). Interacts with NEK8
CC       (PubMed:26967905). Central component of a complex containing at least
CC       ANKS6, INVS, NEK8 and NPHP3 (PubMed:23793029). ANKS6 may organize
CC       complex assembly by linking INVS and NPHP3 to NEK8 and INVS may target
CC       the complex to the proximal ciliary axoneme (PubMed:23793029).
CC       Interacts (via SAM domain) with BICC1 (via KH domains) in an RNA-
CC       dependent manner (By similarity). Interacts (via SAM domain) with ANKS3
CC       (via SAM domain) (PubMed:24998259). {ECO:0000250|UniProtKB:P0C0T2,
CC       ECO:0000269|PubMed:23793029, ECO:0000269|PubMed:24998259,
CC       ECO:0000269|PubMed:26967905}.
CC   -!- INTERACTION:
CC       Q68DC2; Q6RW13-2: AGTRAP; NbExp=3; IntAct=EBI-7054139, EBI-11522760;
CC       Q68DC2; Q92843: BCL2L2; NbExp=3; IntAct=EBI-7054139, EBI-707714;
CC       Q68DC2; O15155: BET1; NbExp=3; IntAct=EBI-7054139, EBI-749204;
CC       Q68DC2; P01031: C5; NbExp=3; IntAct=EBI-7054139, EBI-8558308;
CC       Q68DC2; P50402: EMD; NbExp=3; IntAct=EBI-7054139, EBI-489887;
CC       Q68DC2; P54849: EMP1; NbExp=3; IntAct=EBI-7054139, EBI-4319440;
CC       Q68DC2; P24593: IGFBP5; NbExp=3; IntAct=EBI-7054139, EBI-720480;
CC       Q68DC2; Q9NX47: MARCHF5; NbExp=3; IntAct=EBI-7054139, EBI-2341610;
CC       Q68DC2; Q9UKF7-2: PITPNC1; NbExp=3; IntAct=EBI-7054139, EBI-14223623;
CC       Q68DC2; Q5QGT7: RTP2; NbExp=3; IntAct=EBI-7054139, EBI-10244780;
CC       Q68DC2; B2RUZ4: SMIM1; NbExp=3; IntAct=EBI-7054139, EBI-12188413;
CC       Q68DC2; P0DN84: STRIT1; NbExp=3; IntAct=EBI-7054139, EBI-12200293;
CC       Q68DC2; O15400: STX7; NbExp=3; IntAct=EBI-7054139, EBI-3221827;
CC       Q68DC2; A0PK00: TMEM120B; NbExp=3; IntAct=EBI-7054139, EBI-10171534;
CC       Q68DC2; Q9H2L4: TMEM60; NbExp=3; IntAct=EBI-7054139, EBI-2852148;
CC       Q68DC2; O75379: VAMP4; NbExp=3; IntAct=EBI-7054139, EBI-744953;
CC   -!- SUBCELLULAR LOCATION: Cell projection, cilium
CC       {ECO:0000250|UniProtKB:Q6GQX6}. Cytoplasm
CC       {ECO:0000250|UniProtKB:P0C0T2}. Note=Localizes to the proximal region
CC       of the primary cilium in the presence of INVS.
CC       {ECO:0000250|UniProtKB:Q6GQX6}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q68DC2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q68DC2-3; Sequence=VSP_016496, VSP_016497;
CC       Name=3;
CC         IsoId=Q68DC2-4; Sequence=VSP_016498;
CC   -!- DOMAIN: The ankyrin repeats are necessary and sufficient for NEK8-
CC       binding. {ECO:0000269|PubMed:23793029}.
CC   -!- DOMAIN: The SAM domain mediates interaction with the SAM domain of
CC       ANKS3. {ECO:0000269|PubMed:24998259}.
CC   -!- PTM: Hydroxylated at Asn-138, most probably by HIF1AN. This
CC       hydroxylation results in decreased NEK8-binding.
CC       {ECO:0000250|UniProtKB:P0C0T2}.
CC   -!- DISEASE: Nephronophthisis 16 (NPHP16) [MIM:615382]: A form of
CC       nephronophthisis, a chronic tubulo-interstitial nephritis that
CC       progresses to end-stage renal failure. Some patients have cystic
CC       kidneys of normal size and no extrarenal manifestations, whereas others
CC       have enlarged renal size and severe extrarenal defects, including
CC       hypertrophic obstructive cardiomyopathy, aortic stenosis, pulmonary
CC       stenosis, patent ductus arteriosus, situs inversus, and periportal
CC       liver fibrosis. {ECO:0000269|PubMed:23793029}. Note=The disease is
CC       caused by variants affecting the gene represented in this entry.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH64367.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAC04317.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=CAH18298.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DQ309791; ABC48694.1; -; Genomic_DNA.
DR   EMBL; DQ309777; ABC48694.1; JOINED; Genomic_DNA.
DR   EMBL; DQ309778; ABC48694.1; JOINED; Genomic_DNA.
DR   EMBL; DQ309779; ABC48694.1; JOINED; Genomic_DNA.
DR   EMBL; DQ309780; ABC48694.1; JOINED; Genomic_DNA.
DR   EMBL; DQ309781; ABC48694.1; JOINED; Genomic_DNA.
DR   EMBL; DQ309782; ABC48694.1; JOINED; Genomic_DNA.
DR   EMBL; DQ309783; ABC48694.1; JOINED; Genomic_DNA.
DR   EMBL; DQ309784; ABC48694.1; JOINED; Genomic_DNA.
DR   EMBL; DQ309785; ABC48694.1; JOINED; Genomic_DNA.
DR   EMBL; DQ309786; ABC48694.1; JOINED; Genomic_DNA.
DR   EMBL; DQ309787; ABC48694.1; JOINED; Genomic_DNA.
DR   EMBL; DQ309788; ABC48694.1; JOINED; Genomic_DNA.
DR   EMBL; DQ309789; ABC48694.1; JOINED; Genomic_DNA.
DR   EMBL; DQ309790; ABC48694.1; JOINED; Genomic_DNA.
DR   EMBL; AL353782; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL807776; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CR749467; CAH18298.1; ALT_INIT; mRNA.
DR   EMBL; CR749472; CAH18302.1; -; mRNA.
DR   EMBL; BC064367; AAH64367.1; ALT_INIT; mRNA.
DR   EMBL; AK094247; BAC04317.1; ALT_INIT; mRNA.
DR   CCDS; CCDS43856.1; -. [Q68DC2-1]
DR   RefSeq; NP_775822.3; NM_173551.5. [Q68DC2-1]
DR   RefSeq; XP_006717061.1; XM_006716998.3.
DR   RefSeq; XP_016869934.1; XM_017014445.1.
DR   PDB; 4NL9; X-ray; 1.50 A; C/D=771-840.
DR   PDBsum; 4NL9; -.
DR   AlphaFoldDB; Q68DC2; -.
DR   SMR; Q68DC2; -.
DR   BioGRID; 128464; 56.
DR   CORUM; Q68DC2; -.
DR   FunCoup; Q68DC2; 616.
DR   IntAct; Q68DC2; 37.
DR   MINT; Q68DC2; -.
DR   STRING; 9606.ENSP00000297837; -.
DR   GlyGen; Q68DC2; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q68DC2; -.
DR   PhosphoSitePlus; Q68DC2; -.
DR   BioMuta; ANKS6; -.
DR   DMDM; 83305683; -.
DR   jPOST; Q68DC2; -.
DR   MassIVE; Q68DC2; -.
DR   PaxDb; 9606-ENSP00000297837; -.
DR   PeptideAtlas; Q68DC2; -.
DR   ProteomicsDB; 66071; -. [Q68DC2-1]
DR   ProteomicsDB; 66072; -. [Q68DC2-3]
DR   ProteomicsDB; 66073; -. [Q68DC2-4]
DR   Pumba; Q68DC2; -.
DR   Antibodypedia; 1903; 114 antibodies from 16 providers.
DR   DNASU; 203286; -.
DR   Ensembl; ENST00000353234.5; ENSP00000297837.6; ENSG00000165138.18. [Q68DC2-1]
DR   GeneID; 203286; -.
DR   KEGG; hsa:203286; -.
DR   MANE-Select; ENST00000353234.5; ENSP00000297837.6; NM_173551.5; NP_775822.3.
DR   UCSC; uc004ayu.4; human. [Q68DC2-1]
DR   AGR; HGNC:26724; -.
DR   CTD; 203286; -.
DR   DisGeNET; 203286; -.
DR   GeneCards; ANKS6; -.
DR   GeneReviews; ANKS6; -.
DR   HGNC; HGNC:26724; ANKS6.
DR   HPA; ENSG00000165138; Tissue enhanced (brain).
DR   MalaCards; ANKS6; -.
DR   MIM; 615370; gene.
DR   MIM; 615382; phenotype.
DR   OpenTargets; ENSG00000165138; -.
DR   Orphanet; 93591; Infantile nephronophthisis.
DR   Orphanet; 93592; Juvenile nephronophthisis.
DR   VEuPathDB; HostDB:ENSG00000165138; -.
DR   eggNOG; KOG0504; Eukaryota.
DR   eggNOG; KOG4374; Eukaryota.
DR   GeneTree; ENSGT00940000157664; -.
DR   InParanoid; Q68DC2; -.
DR   OMA; RSPTTWM; -.
DR   OrthoDB; 539213at2759; -.
DR   PAN-GO; Q68DC2; 1 GO annotation based on evolutionary models.
DR   PhylomeDB; Q68DC2; -.
DR   PathwayCommons; Q68DC2; -.
DR   SignaLink; Q68DC2; -.
DR   BioGRID-ORCS; 203286; 101 hits in 1157 CRISPR screens.
DR   ChiTaRS; ANKS6; human.
DR   EvolutionaryTrace; Q68DC2; -.
DR   GenomeRNAi; 203286; -.
DR   Pharos; Q68DC2; Tbio.
DR   PRO; PR:Q68DC2; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   RNAct; Q68DC2; protein.
DR   Bgee; ENSG00000165138; Expressed in cerebellar hemisphere and 137 other cell types or tissues.
DR   ExpressionAtlas; Q68DC2; baseline and differential.
DR   GO; GO:0097543; C:ciliary inversin compartment; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0007368; P:determination of left/right symmetry; IEA:Ensembl.
DR   GO; GO:0007507; P:heart development; IEA:Ensembl.
DR   GO; GO:0001701; P:in utero embryonic development; IEA:Ensembl.
DR   GO; GO:0001822; P:kidney development; IEA:Ensembl.
DR   CDD; cd09518; SAM_ANKS6; 1.
DR   FunFam; 1.25.40.20:FF:000178; Ankyrin repeat and sterile alpha motif domain containing 6; 1.
DR   FunFam; 1.10.150.50:FF:000025; Ankyrin repeat and sterile alpha motif domain-containing 6; 1.
DR   Gene3D; 1.25.40.20; Ankyrin repeat-containing domain; 3.
DR   Gene3D; 1.10.150.50; Transcription Factor, Ets-1; 1.
DR   InterPro; IPR051631; Ankyrin-KH/SAM_domain.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR001660; SAM.
DR   InterPro; IPR013761; SAM/pointed_sf.
DR   PANTHER; PTHR23206; MASK PROTEIN; 1.
DR   PANTHER; PTHR23206:SF7; PROTEIN KINASE DOMAIN-CONTAINING PROTEIN; 1.
DR   Pfam; PF00023; Ank; 2.
DR   Pfam; PF12796; Ank_2; 2.
DR   Pfam; PF00536; SAM_1; 1.
DR   PRINTS; PR01415; ANKYRIN.
DR   SMART; SM00248; ANK; 9.
DR   SMART; SM00454; SAM; 1.
DR   SUPFAM; SSF48403; Ankyrin repeat; 2.
DR   SUPFAM; SSF47769; SAM/Pointed domain; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 7.
DR   PROSITE; PS50105; SAM_DOMAIN; 1.
DR   neXtProt; NX_Q68DC2; -.
DR   PharmGKB; PA134931829; -.
DR   TreeFam; TF328552; -.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ANK repeat; Cell projection;
KW   Ciliopathy; Cilium; Cytoplasm; Disease variant; Hydroxylation;
KW   Joubert syndrome; Nephronophthisis; Phosphoprotein;
KW   Proteomics identification; Reference proteome; Repeat.
FT   CHAIN           1..871
FT                   /note="Ankyrin repeat and SAM domain-containing protein 6"
FT                   /id="PRO_0000067065"
FT   REPEAT          8..37
FT                   /note="ANK 1"
FT   REPEAT          77..106
FT                   /note="ANK 2"
FT   REPEAT          110..139
FT                   /note="ANK 3"
FT   REPEAT          143..172
FT                   /note="ANK 4"
FT   REPEAT          190..219
FT                   /note="ANK 5"
FT   REPEAT          224..253
FT                   /note="ANK 6"
FT   REPEAT          257..289
FT                   /note="ANK 7"
FT   REPEAT          291..321
FT                   /note="ANK 8"
FT   REPEAT          325..354
FT                   /note="ANK 9"
FT   REPEAT          359..388
FT                   /note="ANK 10"
FT   REPEAT          392..423
FT                   /note="ANK 11"
FT   DOMAIN          773..836
FT                   /note="SAM"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00184"
FT   REGION          28..54
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          424..445
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          477..532
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          565..659
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          672..775
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        43..54
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        571..585
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        627..647
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        687..699
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        721..739
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        750..770
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   SITE            823
FT                   /note="Essential for ANKS3 interaction"
FT                   /evidence="ECO:0000250|UniProtKB:P0C0T2"
FT   MOD_RES         138
FT                   /note="3-hydroxyasparagine"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         657
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         734
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         742
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         288..335
FT                   /note="DEEKRRPDIFHALKMGNFQLVKEIADEDPSHVNLVNGDGATPLMLAAV ->
FT                   GQAACPPWLHRGPQIVFMWLKLRIALLEGHAELRVQPCRPLRLRKWCA (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_016496"
FT   VAR_SEQ         336..871
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_016497"
FT   VAR_SEQ         714
FT                   /note="K -> KQ (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_016498"
FT   VARIANT         222
FT                   /note="R -> W (in dbSNP:rs41283630)"
FT                   /evidence="ECO:0000269|PubMed:18434273"
FT                   /id="VAR_070105"
FT   VARIANT         312
FT                   /note="A -> P (in NPHP16; dbSNP:rs1834431706)"
FT                   /evidence="ECO:0000269|PubMed:23793029"
FT                   /id="VAR_070106"
FT   VARIANT         440
FT                   /note="R -> Q (in dbSNP:rs763855876)"
FT                   /evidence="ECO:0000269|PubMed:18434273"
FT                   /id="VAR_070107"
FT   VARIANT         441
FT                   /note="Q -> R (in NPHP16; dbSNP:rs377750405)"
FT                   /evidence="ECO:0000269|PubMed:23793029"
FT                   /id="VAR_070108"
FT   VARIANT         640
FT                   /note="G -> S (in dbSNP:rs749102463)"
FT                   /evidence="ECO:0000269|PubMed:18434273"
FT                   /id="VAR_070109"
FT   VARIANT         644
FT                   /note="V -> I (in dbSNP:rs6415847)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17974005,
FT                   ECO:0000269|PubMed:18434273"
FT                   /id="VAR_034794"
FT   VARIANT         735
FT                   /note="P -> A (in dbSNP:rs79414550)"
FT                   /evidence="ECO:0000269|PubMed:18434273"
FT                   /id="VAR_070110"
FT   MUTAGEN         798
FT                   /note="E->K: Loss of interaction with ANKS3."
FT                   /evidence="ECO:0000269|PubMed:24998259"
FT   MUTAGEN         811
FT                   /note="D->K: Loss of interaction with ANKS3."
FT                   /evidence="ECO:0000269|PubMed:24998259"
FT   MUTAGEN         823
FT                   /note="R->W: Loss of interaction with ANKS3."
FT                   /evidence="ECO:0000269|PubMed:24998259"
FT   CONFLICT        244
FT                   /note="L -> P (in Ref. 3; CAH18298)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        402
FT                   /note="L -> P (in Ref. 4; CAH18302)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        647
FT                   /note="S -> G (in Ref. 5; BAC04317)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        808
FT                   /note="T -> A (in Ref. 4; CAH18302)"
FT                   /evidence="ECO:0000305"
FT   HELIX           778..784
FT                   /evidence="ECO:0007829|PDB:4NL9"
FT   HELIX           788..790
FT                   /evidence="ECO:0007829|PDB:4NL9"
FT   HELIX           791..796
FT                   /evidence="ECO:0007829|PDB:4NL9"
FT   HELIX           801..804
FT                   /evidence="ECO:0007829|PDB:4NL9"
FT   HELIX           809..815
FT                   /evidence="ECO:0007829|PDB:4NL9"
FT   HELIX           820..834
FT                   /evidence="ECO:0007829|PDB:4NL9"
SQ   SEQUENCE   871 AA;  92219 MW;  C4E3AFFE9C9DD6C8 CRC64;
     MGEGGLPPAF QLLLRACDQG DTETARRLLE PGAAEPAERG AEPEAGAEPA GAEVAGPGAA
     AAGAVGAPVP VDCSDEAGNT ALQFAAAGGH EPLVRFLLRR GASVNSRNHY GWSALMQAAR
     FGHVSVAHLL LDHGADVNAQ NRLGASVLTV ASRGGHLGVV KLLLEAGAFV DHHHPSGEQL
     GLGGSRDEPL DITALMAAIQ HGHEAVVRLL MEWGADPNHA ARTVGWSPLM LAALTGRLGV
     AQQLVEKGAN PDHLSVLEKT AFEVALDCKH RDLVDYLDPL TTVRPKTDEE KRRPDIFHAL
     KMGNFQLVKE IADEDPSHVN LVNGDGATPL MLAAVTGQLA LVQLLVERHA DVDKQDSVHG
     WTALMQATYH GNKEIVKYLL NQGADVTLRA KNGYTAFDLV MLLNDPDTEL VRLLASVCMQ
     VNKDKGRPSH QPPLPHSKVR QPWSIPVLPD DKGGLKSWWN RMSNRFRKLK LMQTLPRGLS
     SNQPLPFSDE PEPALDSTMR AAPQDKTSRS ALPDAAPVTK DNGPGSTRGE KEDTLLTTML
     RNGAPLTRLP SDKLKAVIPP FLPPSSFELW SSDRSRTRHN GKADPMKTAL PQRASRGHPV
     GGGGTDTTPV RPVKFPSLPR SPASSANSGN FNHSPHSSGG SSGVGVSRHG GELLNRSGGS
     IDNVLSQIAA QRKKAAGLLE QKPSHRSSPV GPAPGSSPSE LPASPAGGSA PVGKKLETSK
     RPPSGTSTTS KSTSPTLTPS PSPKGHTAES SVSSSSSHRQ SKSSGGSSSG TITDEDELTG
     ILKKLSLEKY QPIFEEQEVD MEAFLTLTDG DLKELGIKTD GSRQQILAAI SELNAGKGRE
     RQILQETIHN FHSSFESSAS NTRAPGNSPC A
//
